288 related articles for article (PubMed ID: 35355615)
21. The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study.
Tamura H; Goto R; Akune Y; Hiratsuka Y; Hiragi S; Yamada M
PLoS One; 2015; 10(7):e0133628. PubMed ID: 26214804
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of a population-based AAA screening program for men over 65 years old in Iran.
Daroudi R; Shafe O; Moosavi J; Salimi J; Bayazidi Y; Zafarghandi MR; Maleki M; Moini M; Farshidmehr P; Sadeghipour P
Cost Eff Resour Alloc; 2021 May; 19(1):29. PubMed ID: 33985531
[TBL] [Abstract][Full Text] [Related]
23. Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System.
Ben ÂJ; Neyeloff JL; de Souza CF; Rosses APO; de Araujo AL; Szortika A; Locatelli F; de Carvalho G; Neumann CR
Appl Health Econ Health Policy; 2020 Feb; 18(1):57-68. PubMed ID: 31674001
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis of a community-based colorectal cancer screening program in Shanghai, China.
Li XP; Chen HM; Lei XH; Dou GS; Chen YC; Chen LP; Zhang Y; Zhao GM; Zhong W
J Dig Dis; 2021 Aug; 22(8):452-462. PubMed ID: 34086400
[TBL] [Abstract][Full Text] [Related]
25. Combined automated screening for age-related macular degeneration and diabetic retinopathy in primary care settings.
Bhuiyan A; Govindaiah A; Alauddin S; Otero-Marquez O; Smith RT
Ann Eye Sci; 2021 Jun; 6():. PubMed ID: 34671718
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration.
Kirkizlar E; Serban N; Sisson JA; Swann JL; Barnes CS; Williams MD
Ophthalmology; 2013 Dec; 120(12):2604-2610. PubMed ID: 24084501
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness analysis of telemedicine to evaluate diabetic retinopathy in a prison population.
Aoki N; Dunn K; Fukui T; Beck JR; Schull WJ; Li HK
Diabetes Care; 2004 May; 27(5):1095-101. PubMed ID: 15111527
[TBL] [Abstract][Full Text] [Related]
28. Cost-Effectiveness of Pediatric Cochlear Implantation in Rural China.
Qiu J; Yu C; Ariyaratne TV; Foteff C; Ke Z; Sun Y; Zhang L; Qin F; Sanderson G
Otol Neurotol; 2017 Jul; 38(6):e75-e84. PubMed ID: 28379918
[TBL] [Abstract][Full Text] [Related]
29. Real-world effectiveness of screening programs for age-related macular degeneration: amended Japanese specific health checkups and augmented screening programs with OCT or AI.
Tamura H; Akune Y; Hiratsuka Y; Kawasaki R; Kido A; Miyake M; Goto R; Yamada M
Jpn J Ophthalmol; 2022 Jan; 66(1):19-32. PubMed ID: 34993676
[TBL] [Abstract][Full Text] [Related]
30. Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists.
van Katwyk S; Jin YP; Trope GE; Buys Y; Masucci L; Wedge R; Flanagan J; Brent MH; El-Defrawy S; Tu HA; Thavorn K
Value Health; 2017 Sep; 20(8):1034-1040. PubMed ID: 28964434
[TBL] [Abstract][Full Text] [Related]
31. Degarelix vs. leuprorelin for the treatment of prostate cancer in China: A cost-utility analysis.
Yan J; Li C; Zhang X; Cheng L; Ding R; Zhang L
Front Public Health; 2022; 10():942800. PubMed ID: 35923949
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.
Lin JK; Moran AE; Bibbins-Domingo K; Falase B; Pedroza Tobias A; Mandke CN; Kazi DS
Lancet Glob Health; 2019 Oct; 7(10):e1346-e1358. PubMed ID: 31477544
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review.
Avidor D; Loewenstein A; Waisbourd M; Nutman A
Cost Eff Resour Alloc; 2020; 18():16. PubMed ID: 32280309
[TBL] [Abstract][Full Text] [Related]
34. Screening for refractive error and fitting with spectacles in rural and urban India: cost-effectiveness.
Frick KD; Riva-Clement L; Shankar MB
Ophthalmic Epidemiol; 2009; 16(6):378-87. PubMed ID: 19995203
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness Analysis of a Personalized, Teleretinal-Inclusive Screening Policy for Diabetic Retinopathy via Markov Modeling.
Dorali P; Shahmoradi Z; Weng CY; Lee T
Ophthalmol Retina; 2023 Jun; 7(6):532-542. PubMed ID: 36621610
[TBL] [Abstract][Full Text] [Related]
36. Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China.
Li R; Zhang K; Lu Z; Mou D; Wang J; Li H; Fan S; Wang N; Liu H
BMJ Open; 2023 Sep; 13(9):e073219. PubMed ID: 37673456
[TBL] [Abstract][Full Text] [Related]
37. Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China.
Xia R; Sun S; Shen M; Zhang L; Zhuang G
Vaccine; 2019 Sep; 37(39):5868-5876. PubMed ID: 31443991
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness analysis of hepatitis E vaccination strategies among patients with chronic hepatitis B in China.
Cui T; Zhang X; Wang Q; Yue N; Bao C; Jiang R; Xu S; Yuan Z; Qian Y; Chen L; Hang H; Zhang Z; Sun H; Jin H
Hepatol Res; 2024 Feb; 54(2):142-150. PubMed ID: 37706554
[TBL] [Abstract][Full Text] [Related]
39. Decision tree-Markov model of perinatal depression screening: a cost-utility analysis.
Yang Y; Zheng R; Yang L; Huang X; Zhang T
Front Public Health; 2024; 12():1308867. PubMed ID: 38832225
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
